Chronic nephropathies

individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model.

Borislav D. Dimitrov, Piero Ruggenenti, Rumen Stefanov, Annalisa Perna, Giuseppe Remuzzi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BACKGROUND/AIMS: To predict risk of end-stage renal disease (ESRD) in individual patients with chronic nephropathy. METHODS: Sequential use of univariate analyses and Cox regression to identify risk factors, artificial neural network to quantify their relative importance and Bayesian analysis to address uncertainty of relationships and incorporate ESRD prevalence information in 344 patients with chronic nephropathy enrolled in the Ramipril Efficacy In Nephropathy study. RESULTS: Serum creatinine (SC), 24-hour urinary protein excretion (UPE) and calcium-phosphorus (Ca*P) product were, in this order, the strongest time-adjusted ESRD predictors. Individual risk of ESRD ranged from near zero when SC and UPE were or =2.41 mg/dl, > or =3 g/24 h and > or =32.64 mg2/dl2, respectively. Receiver operating characteristic curves showed that within lowest, middle and highest tertiles of basal SC (0.90-1.65, 1.66-2.40 and 2.41-6.30 mg/dl, respectively) the model accurately predicted ESRD (AUC = 0.80, 0.72 and 0.65; p = 0.0003, 0.0001 and 0.0022, respectively), quality of life or treatment costs. CONCLUSION: Integrated use of regression analysis and probabilistic models allows computation of individual risk of progression to ESRD and related utilities. This may help in optimizing care and costs in nephrology and other medical areas and designing trials in high-risk patients.

Original languageEnglish
JournalNephron - Clinical Practice
Volume95
Issue number2
Publication statusPublished - 2003

Fingerprint

Statistical Models
Chronic Kidney Failure
Creatinine
Serum
Regression Analysis
Ramipril
Bayes Theorem
Nephrology
ROC Curve
Health Care Costs
Phosphorus
Uncertainty
Area Under Curve
Proteins
Quality of Life
Calcium
Costs and Cost Analysis

Cite this

Chronic nephropathies : individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model. / Dimitrov, Borislav D.; Ruggenenti, Piero; Stefanov, Rumen; Perna, Annalisa; Remuzzi, Giuseppe.

In: Nephron - Clinical Practice, Vol. 95, No. 2, 2003.

Research output: Contribution to journalArticle

@article{4daee77878f044418b76749e6daeb8dd,
title = "Chronic nephropathies: individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model.",
abstract = "BACKGROUND/AIMS: To predict risk of end-stage renal disease (ESRD) in individual patients with chronic nephropathy. METHODS: Sequential use of univariate analyses and Cox regression to identify risk factors, artificial neural network to quantify their relative importance and Bayesian analysis to address uncertainty of relationships and incorporate ESRD prevalence information in 344 patients with chronic nephropathy enrolled in the Ramipril Efficacy In Nephropathy study. RESULTS: Serum creatinine (SC), 24-hour urinary protein excretion (UPE) and calcium-phosphorus (Ca*P) product were, in this order, the strongest time-adjusted ESRD predictors. Individual risk of ESRD ranged from near zero when SC and UPE were or =2.41 mg/dl, > or =3 g/24 h and > or =32.64 mg2/dl2, respectively. Receiver operating characteristic curves showed that within lowest, middle and highest tertiles of basal SC (0.90-1.65, 1.66-2.40 and 2.41-6.30 mg/dl, respectively) the model accurately predicted ESRD (AUC = 0.80, 0.72 and 0.65; p = 0.0003, 0.0001 and 0.0022, respectively), quality of life or treatment costs. CONCLUSION: Integrated use of regression analysis and probabilistic models allows computation of individual risk of progression to ESRD and related utilities. This may help in optimizing care and costs in nephrology and other medical areas and designing trials in high-risk patients.",
author = "Dimitrov, {Borislav D.} and Piero Ruggenenti and Rumen Stefanov and Annalisa Perna and Giuseppe Remuzzi",
year = "2003",
language = "English",
volume = "95",
journal = "Nephron - Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Chronic nephropathies

T2 - individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model.

AU - Dimitrov, Borislav D.

AU - Ruggenenti, Piero

AU - Stefanov, Rumen

AU - Perna, Annalisa

AU - Remuzzi, Giuseppe

PY - 2003

Y1 - 2003

N2 - BACKGROUND/AIMS: To predict risk of end-stage renal disease (ESRD) in individual patients with chronic nephropathy. METHODS: Sequential use of univariate analyses and Cox regression to identify risk factors, artificial neural network to quantify their relative importance and Bayesian analysis to address uncertainty of relationships and incorporate ESRD prevalence information in 344 patients with chronic nephropathy enrolled in the Ramipril Efficacy In Nephropathy study. RESULTS: Serum creatinine (SC), 24-hour urinary protein excretion (UPE) and calcium-phosphorus (Ca*P) product were, in this order, the strongest time-adjusted ESRD predictors. Individual risk of ESRD ranged from near zero when SC and UPE were or =2.41 mg/dl, > or =3 g/24 h and > or =32.64 mg2/dl2, respectively. Receiver operating characteristic curves showed that within lowest, middle and highest tertiles of basal SC (0.90-1.65, 1.66-2.40 and 2.41-6.30 mg/dl, respectively) the model accurately predicted ESRD (AUC = 0.80, 0.72 and 0.65; p = 0.0003, 0.0001 and 0.0022, respectively), quality of life or treatment costs. CONCLUSION: Integrated use of regression analysis and probabilistic models allows computation of individual risk of progression to ESRD and related utilities. This may help in optimizing care and costs in nephrology and other medical areas and designing trials in high-risk patients.

AB - BACKGROUND/AIMS: To predict risk of end-stage renal disease (ESRD) in individual patients with chronic nephropathy. METHODS: Sequential use of univariate analyses and Cox regression to identify risk factors, artificial neural network to quantify their relative importance and Bayesian analysis to address uncertainty of relationships and incorporate ESRD prevalence information in 344 patients with chronic nephropathy enrolled in the Ramipril Efficacy In Nephropathy study. RESULTS: Serum creatinine (SC), 24-hour urinary protein excretion (UPE) and calcium-phosphorus (Ca*P) product were, in this order, the strongest time-adjusted ESRD predictors. Individual risk of ESRD ranged from near zero when SC and UPE were or =2.41 mg/dl, > or =3 g/24 h and > or =32.64 mg2/dl2, respectively. Receiver operating characteristic curves showed that within lowest, middle and highest tertiles of basal SC (0.90-1.65, 1.66-2.40 and 2.41-6.30 mg/dl, respectively) the model accurately predicted ESRD (AUC = 0.80, 0.72 and 0.65; p = 0.0003, 0.0001 and 0.0022, respectively), quality of life or treatment costs. CONCLUSION: Integrated use of regression analysis and probabilistic models allows computation of individual risk of progression to ESRD and related utilities. This may help in optimizing care and costs in nephrology and other medical areas and designing trials in high-risk patients.

UR - http://www.scopus.com/inward/record.url?scp=1542441761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542441761&partnerID=8YFLogxK

M3 - Article

VL - 95

JO - Nephron - Experimental Nephrology

JF - Nephron - Experimental Nephrology

SN - 0028-2766

IS - 2

ER -